Study
| EST. READ TIME 1 MIN.Access Delayed, Access Denied: Waiting for New Medicines in Canada 2007
This report analyzes the total time patients must wait in Canada to gain access to newly invented pharmaceutical and biological medicines, also known as patented drugs. The purpose of this report is twofold: (1) to draw attention to the impact that Canadian public policies and institutions have on the time it takes for patients to gain access to new medicines; and (2) to contribute to the policy discussion about the relative performance of government drug-insurance programs in providing timely coverage for new medicines compared to private-sector drug insurance in Canada.
Share
-
Brett J. Skinner
Brett J. Skinner Dr. Brett J. Skinner was the Fraser Institutes Director of Health Policy Research (2004 to 2012) andwas also the Institutes President and CEO (2010 and 2012). Dr. Skinner has a B.A. from the University of Windsor, an M.A. through joint studies between the University of Windsor and Wayne State University in Detroit (Michigan), and a Ph.D. from the University of Western Ontario, where he has lectured in both the Faculty of Health Sciences and the Department of Political Science. Dr. Skinner has authored or co-authored approximately 50 major original pieces of applied economics and public policy research. In 2003 he was a co-winner of the Atlas Economic Research Foundations Sir Antony Fisher Memorial Award for innovative projects in public policy. Dr. Skinners book, Canadian Health Policy Failures: Whats wrong? Who gets hurt? Why nothing changes, was a finalist for Atlas 2009 Fisher book prize. His research has been published through several think-tanks including the Fraser Institute (Vancouver), the Atlantic Institute for Market Studies (Halifax), the Pacific Research Institute (San Francisco), the American Enterprise Institute (Washington, D.C.) and the Israel National Institute for Health Policy Research (Israel). His work has also been published in several academic journals including Economic Affairs, Pharmacoeconomics and Alimentary Pharmacology & Therapeutics. Dr. Skinner appears and is cited frequently as an expert in the Canadian, American, and global media. He has presented his research at conferences and events around the world, including testifying before the House of Commons Standing Committee on Health in Ottawa, and briefing bi-partisan Congressional policy staff at the U.S. Capitol in Washington, D.C.… Read more Read Less… -
Mark Rovere
-
Courtney Glen
Courtney Glen has an MSc in International and European Politics from the University of Edinburgh in Scotland and was a2006 research intern in the Department of Health and Pharmaceutical Policy Research at The Fraser Institute.… Read more Read Less…
Related Topics
Related Articles
AI could help solve Canada’s shortage of family doctors
By: Dr. Jehangir Appoo, Glen Sumner and Aria S. Appoo
Philpott should act on instincts and promote Dutch-style health-care reform in Ontario
By: Bacchus Barua and Mackenzie Moir
Canadians are ready for health-care reform—Australia shows the way
By: Bacchus Barua and Mackenzie Moir
Canadians want major health-care reform now
By: Mackenzie Moir